JCO Study Confirms Annual Mammograms Improve Breast Cancer Outcomes Across All Demographics
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn about a recent paper by Margarita Zuley et al. published in JCO.
Authors: Margarita Zuley, Andriy Bandos, Stephen Duffy, Durwin Logue, Rohit Bhargava, Priscilla McAuliffe, Adam Brufsky and Robert Nishikawa.
“New JCO Study Shows Better Patient Outcomes with Annual Breast Cancer Screening.
A recent study in JCO provides evidence that annual mammograms lead to lower rates of late-stage breast cancer diagnosis and improved overall survival regardless of age, race, or menopausal status.
In a study of 8,145 patients, those who received annual mammograms saw a marked reduction in late-stage cancers compared to those screened every two years or less frequently. These findings support the current recommendations from the ACR for annual screening for those 40 and older.”
Source: ASCO/X
The American Society of Clinical Oncology (ASCO) is a leading professional organization representing nearly 45,000 physicians and oncology specialists worldwide, dedicated to cancer care. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, ASCO is committed to advancing cancer research, education, prevention, and high-quality patient care.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023